Topical Voriconazole as Supplemental Treatment for Acanthamoeba Keratitis
Conclusions:
Topical voriconazole 1% combined with first-line therapy composed of polyhexamethylene biguanide 0.02% and propamidine isethionate 0.1% appears to be an effective option with minor side effects for the treatment of AK.
Source: Cornea - Category: Opthalmology Tags: Clinical Science Source Type: research
More News: Acanthamoeba Keratitis | Corneal Transplant | Eyes | Free Living Amoebozoa Infection | Opthalmology | Science | Study | Women